The AGACNP is beginning medical management of a patient newly diagnosed with T2DM.
. The AGACNP is beginning medical management of a patient newly
diagnosed with T2DM. The patient has a BMI of 39 and has been unsuccessful in making significant diet and lifestyle changes over the last six months. Other than her weight, her physical examination is essentially within normal limits. Her HgbA1c is 9.5%. A basic metabolic panel is within normal limits. The medication of choice to begin therapy will be:
A.
A sulfonyurea
B.
A meglitinide
C.
A biguanide
D.
An incretin mimetic